Tests for TCA and MDMA have been added to a menu of nine other drugs (amphetamines, methamphetamine, opiates, cocaine, PCP, THC, benzodiazepines, barbiturates and methadone)
Bio-Rad Laboratories has announced the introduction of two new tests (May 2003) for use with the company's Tox/See rapid urine drug screen device.
The new tests for TCA (tricyclic antidepressants) and MDMA (Ecstasy) have been added to a test menu of nine other drugs (amphetamines, methamphetamine, opiates, cocaine, PCP, THC, benzodiazepines, barbiturates and methadone).
Tox/See is an FDA-cleared, hand-held drug screening device that is used in hospitals, diagnostic laboratories, correctional facilities, police departments, work environments and drug rehabilitation facilities.
This fast, one-step point-of-care testing device provides results in as few as three minutes.
As drug abuse continues to increase, fast and comprehensive drug testing is more important than ever.
The new Tox/See nine-drug panel is designed to provide information in as few as three minutes for the most commonly abused drugs including TCA.
Estimates indicate that there are seven million Ecstasy-abusers worldwide and it appears that this number is on the rise.
Providing a specific and reliable test for this drug, therefore, is increasingly important.
Bio-Rad's new Tox/See MDMA test offers high specificity and detects all three forms of Ecstasy: MDMA, MDA and MDEA.
Tox/See panels are widely used in hospitals, diagnostic laboratories, drug rehabilitation centers, workplaces and law enforcement markets as an alternative to larger, more costly automated toxicology screening instruments.
